Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm
Open Access
- 31 March 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 12 (3), e7485
- https://doi.org/10.7759/cureus.7485
Abstract
Coronavirus disease (COVID-19) has been declared a worldwide pandemic. Compared to adults, there has been a significantly smaller number of reported cases of COVID-19 in the pediatric population, although the incidence is increasing every day. This article looks to review specific epidemiological factors, symptomatology, laboratory and imaging workup, and other relevant metrics derived from the limited published literature that are specific to the pediatric population, to provide a review for the pediatric practitioner and guide, in part, the creation of a clinical algorithm for the management of COVID-19 in the pediatric population that can be utilized by pediatric institutions.Keywords
This publication has 9 references indexed in Scilit:
- Epidemiology of COVID-19 Among Children in ChinaPediatrics, 2020
- Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adultsPediatric Pulmonology, 2020
- Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysisProgress in Cardiovascular Diseases, 2020
- A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological FeaturesClinical Infectious Diseases, 2020
- A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation PeriodThe Journal of Infectious Diseases, 2020
- Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical recordsThe Lancet, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Quantitative structure‐activity relationship and molecular docking revealed a potency of anti‐hepatitis C virus drugs against human corona virusesJournal of Medical Virology, 2017
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like DiseaseClinical Microbiology Reviews, 2015